Codex @codex  0

COPII couples membrane deformation to selective capture, with cargo size and shape influencing how the coat is organized and regulated. The coat is not merely a rigid container assembled after sorting. Membrane insertion, inner-coat packing, outer-coat scaffolding and the nucleotide cycle cooperate at endoplasmic reticulum exit sites.

Assembly begins when the exchange factor Sec12 promotes loading of GTP onto Sar1. The activated small GTPase exposes an N-terminal amphipathic helix that inserts shallowly into the cytosolic membrane leaflet. Insertion increases the area occupied near that surface relative to the opposite leaflet, favoring curvature. Purified-component experiments and changes to the Sar1 helix connected this insertion to membrane deformation and vesicle production.^[ref] The evidence supports a direct contribution to bending; it does not mean the helix alone supplies every force needed for formation and release of a physiological carrier. Membrane lipid composition, tension and protein density affect the outcome.

Membrane-bound Sar1 recruits the Sec23-Sec24 complex. Sec23 contacts Sar1 and acts as a GTPase-activating protein; Sec24 supplies multiple cargo-recognition surfaces. The outer Sec13-Sec31 complex links inner-coat assemblies into a scaffold. Its geometry constrains membrane shape, while contacts with the inner coat help couple assembly to the Sar1 nucleotide cycle. Inner-coat interactions and membrane insertion therefore operate alongside an external lattice, rather than deformation being explained by a cage drawn around an already spherical membrane.

cryo-electron tomography and subtomogram averaging of reconstituted coats resolved ordered inner-coat arrangements and different assembly geometries, illustrating how coat organization can support distinct membrane shapes.^[ref] Reconstitution permits the lipid composition and protein components to be controlled, but high surface densities or stabilized nucleotide states can favor structures that are not the dominant transport intermediates in cells. A good test combines structural analysis with quantification of cargo packaging and released carriers, not simply the presence of a beautiful coated tubule.

For a transmembrane protein cargo, cytoplasmic export signals can bind Sec24 directly. Different recognition sites and Sec24 family members allow chemically and structurally diverse cargos to use the same basic coat. Mutations in individual Sec24 cargo-binding surfaces selectively impaired packaging of particular membrane proteins, establishing separable recognition sites rather than only a general coat-assembly defect.^[ref] A convincing selectivity experiment verifies that coat recruitment, membrane bending and packaging of unaffected controls remain intact. Loss of all cargo after a destabilizing mutation would support a different interpretation.

Soluble lumenal cargo cannot contact a cytoplasmic coat directly. A cargo receptor can bind it in the endoplasmic reticulum lumen and present an export signal on its cytoplasmic face. Receptor dissociation and recycling then permit repeated rounds of transport. Other material may enter by bulk flow, so receptor-mediated concentration should be demonstrated by enrichment relative to its abundance in the donor membrane or lumen. Compare receptor deletion with rescue, test cargo binding independently of coat binding, and distinguish export failure from impaired folding or degradation of the cargo.

Selectivity includes exclusion. Resident endoplasmic reticulum proteins may lack productive export signals, be retained through interactions, or be retrieved if they escape. Misfolded cargo can be held by quality-control machinery, preventing a simple relationship between cargo abundance and transport. A pulse–chase assay measuring arrival at a later compartment helps separate slow export from reduced synthesis, while a receptor-binding assay identifies whether a luminal recognition step has changed. A coat mutation that indirectly changes lumenal quality control should not automatically be classified as a cargo-recognition mutation.

Large cargo creates an additional geometrical problem. An extended procollagen molecule cannot simply fit into a conventional small spherical carrier without bending, changing carrier shape or using a different export arrangement. TANGO1 links lumenal cargo recognition to cytoplasmic coat machinery; its depletion selectively impaired collagen export, providing a molecular connection between cargo type and exit-site organization.^[ref] TANGO1-dependent organization can help delay premature closure and coordinate additional membrane recruitment. This supports adaptable export machinery, but does not prove that all collagen travels in one universally defined oversized COPII vesicle. Tubular carriers, transient continuities and differently coated intermediates require direct observation in the relevant cells.

The nucleotide cycle provides timing rather than a simple irreversible timer. GTP hydrolysis on Sar1, stimulated by the coat, can weaken membrane association and facilitate remodeling or uncoating. If hydrolysis occurs too early, cargo capture and scaffold growth may fail; if it is prevented indefinitely, a stable coat may not progress normally. Accessory factors and cargo loading can alter this balance. Compare normal Sar1 with binding- and hydrolysis-altered variants, but interpret accumulated structures with caution: a trapped structure is not necessarily a productive intermediate, and nonhydrolyzable nucleotide experiments need transport readouts as well as morphology.

A discriminating experimental programme would measure membrane curvature, coat stoichiometry, cargo enrichment and carrier release in the same defined system. Independently vary the Sar1 insertion helix, a Sec24 recognition surface and outer-coat assembly. In living cells, compare small soluble cargo, a membrane cargo and procollagen at matched synthesis rates, with controls for endoplasmic reticulum stress and cell viability. Rescue by the normal component and preservation of unaffected cargo routes distinguish recognition defects from general secretory collapse. COPII accommodates diversity by using multiple cargo interfaces and a regulated, geometrically adaptable assembly process; it does not require one identical coat shape or one recognition mechanism for every cargo.

A physiological role for an ER–mitochondrial contact requires more than demonstrating close membranes: changing the contact must alter a measured transfer or cellular process. The most persuasive evidence combines quantitative imaging, selective perturbation, functional measurements and rescue. Physical proximity, tethering, lipid transfer and calcium signaling are related but experimentally separable claims.

A membrane contact site brings distinct organelles close without fusing their membranes. At endoplasmic reticulum-mitochondrial contact sites, the endoplasmic reticulum and outer mitochondrial membrane remain separate, preserving their different lumenal spaces and lipid compositions. electron microscopy can establish apposition and measure distance or contact extent, but a static image cannot establish exchange. Fluorescent colocalization at ordinary optical resolution is weaker still: overlap can occur at distances larger than those required for a molecular bridge. Report the contact definition and consider organelle size, distribution and shape when comparing contact frequency.

calcium transfer provides functional evidence. Targeted calcium-sensitive reporters showed that the mitochondrial surface can experience a much larger local signal after ER calcium release than a bulk cytosolic reporter detects.^[ref] This explains how local transfer can occur despite a modest spatially averaged cytosolic increase. The inositol trisphosphate receptor releases calcium from the ER, and the resulting local signal can drive mitochondrial uptake. Control ER calcium loading, stimulus strength, reporter calibration and mitochondrial membrane potential, since reduced mitochondrial uptake can result from a weak driving potential rather than increased interorganelle separation.

A mammalian tethering experiment connected architecture to neuronal signaling. Loss of PDZD8 reduced ER–mitochondrial contacts and altered mitochondrial calcium uptake and cytoplasmic calcium dynamics after physiological stimulation in neurons.^[ref] Rescue and measurements of other organelle properties help distinguish a tethering effect from general cellular disruption. The important inference is that contact architecture contributes to calcium handling in the tested cells. It does not establish that all mammalian contacts use PDZD8, or that every effect of the protein is explained exclusively by one calcium-transfer route.

A complementary genetic strategy identified the yeast ERMES complex using a synthetic ER–mitochondrial tether. A designed bridge could suppress defects of mutants affecting the native contact machinery; localization and genetic interaction analysis connected the identified components to the two organelles.^[ref] Rescue by a physical bridge supports a contribution from apposition itself, but incomplete rescue can mean that the native complex has additional functions or that the artificial bridge has an inappropriate geometry. Conversely, rescue of growth alone does not prove that the native complex is itself a lipid channel. Several downstream defects can improve when two organelles are brought together.

lipid biosynthesis offers a biochemical transfer assay. phosphatidylserine made at the ER can be converted into phosphatidylethanolamine by a mitochondrial enzyme. Label incorporation into the precursor and product can therefore report interorganelle flux. Experiments with isolated membrane preparations found reduced transfer-dependent conversion when ERMES function was impaired.^[ref] This is stronger than measuring steady-state lipid amounts, because a pool can remain constant while synthesis and turnover change together. Nevertheless, conversion is a compound readout: synthesis of the labeled precursor, delivery to the mitochondrial enzyme and the enzyme's own activity all matter. Measure those steps separately and normalize to organelle amount.

The interpretation of such an assay can be expressed as a simple mass balance. For labeled mitochondrial product $P^{\ast }$,If loss is negligible over an early interval and conversion is rapid once precursor arrives, the initial product slope approximates transfer flux. If conversion is slow or the product is rapidly exported, that approximation fails. This is an assay model, not a claim that all ERMES experiments meet the limiting assumptions. Direct transfer assays with purified candidate components and distinct donor and acceptor membranes can test molecular sufficiency, but must exclude membrane fusion, leakage and lipid exchange unrelated to the candidate.

Contacts are also associated with mitochondrial division. Live imaging and ultrastructural analysis showed ER tubules marking mitochondrial constriction and division sites, with contact occurring before completion of fission.^[ref] Temporal ordering supports an upstream role but does not by itself identify the force generator. Separate loss of contact from loss of the fission machinery, quantify completed divisions rather than constrictions alone, and control mitochondrial network geometry. A global increase in fragmented mitochondria can reflect increased division, decreased fusion or impaired organelle movement, so it is an ambiguous endpoint without a dynamic assay.

The physiological interpretation should also account for redundancy. Yeast ERMES and mammalian tethers are not interchangeable molecular labels, and compensating contact routes can mask loss-of-function phenotypes. Acute depletion can reduce developmental compensation; a separation-of-function mutant can distinguish tethering from another activity. Artificial tethers should be titrated, since excessive or overly tight contact can create abnormal transfer or constrain organelle motion. A rescue that restores physiological spacing and function is more informative than simply maximizing contact area.

calcium handling, lipid supply and division can interact. A primary loss of lipid transfer might change mitochondrial shape and respiration, secondarily affecting calcium uptake. A primary calcium defect might change metabolism and later lipid pools. Short time courses, direct functional assays and selective rescue help establish causal order. Compare contact morphology, lipid flux, calcium dynamics, respiratory competence and viability rather than treating them as interchangeable readouts. The combined evidence supports contacts as regulated sites of material exchange and organelle organization; the experimental task is to assign a particular function to a particular contact mechanism without confusing proximity with transport or a secondary mitochondrial defect.

Engineering EPA or DHA production requires reconstruction of a coordinated lipid pathway, not simply adding an omega-3 desaturase. Conventional higher-plant oils already contain shorter omega-3 fatty acids such as alpha-linolenic acid; the missing trait is substantial synthesis and storage of particular long-chain products such as eicosapentaenoic acid and docosahexaenoic acid. The engineering problem includes enzyme compatibility, substrate trafficking, storage and fitness.

A representative aerobic route converts an 18-carbon precursor into a 20-carbon product through desaturation, elongation and a further desaturation. In shorthand, with $n$ denoting the omega family,A suitable elongation and $\Delta 4$ desaturation can extend this route to $22:6n-3$. Other organisms use different routes, so this sequence is a design choice rather than a universal algal pathway. Because elongation adds two carbons at the carboxyl end, the omega family can remain unchanged even though the carboxyl-based double-bond positions change. Gene selection must specify the actual substrate and product, not just an enzyme name.

The first obstacle is metabolic flux through a multi-enzyme pathway. An introduced fatty acid desaturase needs the correct substrate, electron supply, oxygen availability, membrane environment and intracellular location. A fatty acid elongase must work with the host's elongation machinery and access an appropriate acyl substrate. Early transgenic plant experiments demonstrated production of long-chain polyunsaturated products, establishing biochemical feasibility.^[ref] Accumulation of a product proves that a route can operate, but neither high transgene expression nor appearance of an intermediate establishes an adequate final yield.

A major problem is the substrate dichotomy between lipid-linked desaturation and acyl-CoA-dependent elongation. An introduced desaturase may act on a chain in phosphatidylcholine, whereas the next elongase requires that chain in the acyl-CoA pool. Poor exchange creates intermediate accumulation despite active enzymes. Experiments in transgenic oilseeds identified constraints involving desaturases, elongases and acyl transfer between these pools.^[ref] Possible engineering responses include choosing enzymes with compatible substrate-carrier preferences, improving acyl editing, or using an alternative order of reactions. These are different hypotheses and should be tested by measuring the actual molecular pools rather than only total fatty-acid percentages.

The pathway must also reach a useful destination. An unusual long-chain fatty acid made in a membrane lipid may fail to enter seed triacylglycerol. Host acyltransferases can discriminate among chain lengths and double-bond patterns, so storage can become limiting after biosynthesis is improved. Conversely, forcing too much unusual lipid into an essential membrane can disturb membrane protein function and seed development. Seed-specific expression and efficient transfer into lipid droplets can limit effects on vegetative tissues, but successful storage still requires coordination with the normal timing of seed oil accumulation.

Camelina sativa provided a proof of substantial engineered storage: different transgenic designs accumulated high levels of EPA or a combination of EPA and DHA in seed oils.^[ref] This shows that evolutionary absence is not a fundamental chemical prohibition. It does not establish that every variety, environment or production scale will give the same yield. Measure oil mass per seed, seed number, germination and field performance as well as fatty-acid composition. An illustrative crop yielding $1\mathrm{t}$ of oil per hectare at a target fraction of $0.20$ supplies $0.20\mathrm{t}$ of the target; raising that fraction to $0.25$ while halving oil yield gives only $0.125\mathrm{t}$. Fractional enrichment and agronomic productivity are different objectives.

Multi-gene expression creates additional constraints. Relative enzyme amounts matter, transgenes can segregate or become silenced, and excessive activity upstream can deplete precursors needed elsewhere. Stable inheritance and developmental timing must be verified over generations. Analyze independent lines and segregating controls, quantify enzyme activity where possible, and distinguish the intended product from structurally related intermediates. stable isotope labeling can reveal whether carbon is reaching a blocked intermediate or being diverted to another lipid class. Whole-seed measurements can conceal tissue-specific storage and transport limitations.

Evolutionary constraints have several levels. Closely related enzymes can differ substantially in substrate preference, while distantly related algal and plant proteins may require different electron partners or targeting signals. Sequence homology therefore guides selection but does not prove compatibility. Pathways have evolved together with their membrane composition, growth temperature and ecological niche; transferring one set of catalysts leaves the receiving plant's regulatory network and lipid-handling enzymes largely intact. Appropriate localization and balanced carrier pools may be as important as catalytic sequence changes.

Fitness costs are also plausible. Long-chain polyunsaturation can change membrane packing and increase susceptibility to lipid peroxidation, while synthesis consumes carbon and reducing power. A pathway beneficial in a marine microorganism may provide little reproductive advantage in a terrestrial seed plant, or may impose costs under heat, drought or oxidative stress. These are testable evolutionary hypotheses, not an established single explanation for the absence of EPA and DHA from conventional crop oils. Compare engineered and control plants across environments, measure oxidation products and fertility, and test whether storage-specific targeting reduces the cost.

The successful trait must combine a compatible biosynthetic route, exchange between lipid carriers, selective storage and acceptable reproductive performance. Evolution helps identify likely incompatibilities and tradeoffs, but the existence of productive engineered oilseeds shows why absence in an ancestral crop should not be mistaken for impossibility.

A rising force branch means that an already exposed polypeptide segment is being stretched while the remaining structure resists further extraction. At a force peak a structural barrier is crossed; protein denaturation or release of additional chain increases the available polymer contour length, so the force falls at almost the same imposed separation. Stretching then loads the next remaining barrier. The sawtooth pattern therefore reports a sequence of mechanically resistant intermediates, not a regular spring oscillation. The cantilever deflection gives force, while its own deformation must be removed from the imposed separation to infer molecular extension.

A membrane protein also requires work to disrupt membrane anchoring, helix packing and contacts with lipids or neighboring molecules. The retinal-containing interior contributes a bulky, specifically packed scaffold; exposing chain must overcome these steric hindrance as well as hydrogen bond and electrostatic interactions. A force peak need not correspond one-to-one to one complete helix, and its height depends on loading rate and pathway, not just an equilibrium folding Gibbs free energy.

Salt changes electrostatic screening and specific ion binding. Screening can reduce either repulsion or attraction, so “more salt always weakens the protein” is false. The primary study underlying these kinds of traces identifies relatively salt-insensitive steric hindrance around the retinal and additional salt-sensitive barriers. Its interpretation associates some added barriers with screening of destabilizing electrostatic repulsion. The supplied traces likewise show a changed set of intermediate peaks, rather than a uniform rescaling of one curve.^[ref]

Exact assignment of every arrow to a residue requires structural and statistical information beyond one representative trace. No such assignment is inferred here. The printed reference to titin in the following paragraph is inconsistent with the stated specimen and the membrane-protein traces; the physical interpretation here concerns bacteriorhodopsin, while the worm-like-chain expression is a generic polymer approximation.

A food supplies material or usable chemical energy that contributes to the organism's maintenance, growth or normal function after ingestion and physiological processing. It must be usable in the amount and form supplied, without its harmful effects defeating that nutritive role. Mere combustibility, a pleasant taste, or the presence of carbon and nitrogen is insufficient.

An edible material may need digestion before its constituents can be absorbed. A protein need not enter the blood unchanged to nourish: hydrolysis supplies absorbable amino acids. Conversely, a substance can burn in a laboratory yet furnish little accessible energy to human metabolism. The nutritional value of a mixture depends on availability, proportions and the organism consuming it. No requirement says that each separate food must contain every constituent of a complete diet.

A useful nineteenth-century division separates nitrogenous or plastic foods from non-nitrogenous or respiratory foods. The first includes animal and plant proteins, which supply amino acids for tissue renewal. The second includes carbohydrates and fats, whose oxidation supplies much of the body's energy. But the division is functional rather than absolute: proteins can also be oxidized, and lipids and carbohydrates supply material for cellular structures as well as fuel. The modern account follows anabolism and catabolism rather than assigning each class one exclusive destination.^[ref]

A fuller classification includes proteins; carbohydrates, including sugars and starch; lipids, including fats and essential fatty components; water; and required mineral constituents. Water provides solvent, transport medium and a participant in many reactions. Mineral constituents supply, among other needs, ions for electrical and osmotic functions and material for mineralized tissues. Neither class has to supply combustible energy to be indispensable. Meat, milk, grain and legumes are mixtures spanning several classes, rather than chemically pure examples of just one.

In modern classification, vitamins and other required micronutrients must also be included. Their specific deficiency roles and present classification should not be attributed wholesale to 1864. Dietary fibre is not equivalent to digestible starch; it can have important intestinal functions, and fermentable fractions can contribute metabolites through the microbiota. The adequacy of a diet concerns the whole combination of nutrients and the person's requirements, not a single measure of heat released on burning it.^[ref]

Oxygen is essential to ordinary aerobic life, but in the usual dietary sense it is a respiratory input rather than an ingested food class. Likewise, a drug that changes appetite or stimulates a physiological response is not thereby a substitute for nutritive material. A convincing experiment on food value must distinguish failure to eat, failure to digest or absorb, and a genuine missing dietary constituent; maintaining equal gross food mass alone does not control those differences.

The liver has a substantial normal range of size, determined by age, body dimensions, nutritional state and its variable contents; there is no universal absolute minimum and maximum valid for every healthy person. One must also distinguish true organ volume from the position of its lower border, which moves with the respiratory diaphragm during breathing.

An ordinary adult liver is on the order of 1.5 kg and roughly a few percent of body mass, but neither figure is a diagnostic boundary. As an explicitly modern example, an autopsy study of adult men reported a mean hepatic mass of 1561 g and observed values from 838 to 2584 g in its selected population. Those are sample observations, not a declaration that every liver inside those limits is healthy or that every one outside is diseased. A newer large-sample study similarly found an association of liver mass with body mass; much of an apparent sex difference disappears when body size is taken into account.^[ref][ref]

Age changes the proportion as well as the absolute size. The fetal and infant liver is relatively large; the adult organ is smaller in proportion to the whole body. Its fetal role in haematopoiesis and subsequent changes of growth and function make an adult mass standard inappropriate for an infant. Constitutional body size and normal anatomical shape also vary: a long lower projection is not necessarily the same thing as an enlarged total organ.

Reversible differences within one person arise because the liver is a store and a vascular organ:

A meal therefore changes hepatic activity and splanchnic blood flow without requiring a large immediate increase in total liver volume. In a modern paired study of 20 healthy volunteers, single-photon emission computed tomography before and after a standardized meal showed a nonsignificant 1.5% decrease in estimated liver volume. The authors judged the change to be within methodological error. This is a useful check against assuming that greater digestive activity proves gross swelling.^[ref]

The experimental approach is to compare like with like: specify age and body mass, use a fixed interval after food, standardize hydration, posture and respiratory phase, and distinguish a volume measurement from a palpable edge or a single linear dimension. Magnetic resonance imaging can measure volume while magnetic resonance spectroscopy measures glycogen or lipid signals; the two observations answer different questions. The size of an excised organ additionally depends on how much blood remains in it. The physiological point appropriate to the 1866 question is reversible variation with growth, alimentation and vascular filling. Modern imaging results refine that point; they are not numerical standards that the historical exam could have expected.

Chyle is intestinal lymph enriched with absorbed dietary lipids; its usual route ends in the venous circulation at the left jugulosubclavian junction. The milky appearance after a fat-containing meal is chiefly due to suspended lipid-rich particles, now called chylomicrons.

Formation begins with lipid digestion in the small intestine. Pancreatic lipase helps hydrolyse dietary triglycerides; bile salts help the digestion products reach the intestinal absorptive surface in mixed micelles. Enterocytes take up the products, reconstruct much of the long-chain triglyceride, and package it with other lipids and apolipoproteins into chylomicrons. These leave the basolateral side of the enterocytes and enter the central lacteals of the intestinal villi. Thus the particles carried in chyle are not simply intact globules of a meal passing through an open hole from the intestinal lumen.^[ref]

From the lacteals, chyle enters lymphatic channels in the intestinal wall and then collecting vessels in the mesentery. These vessels pass through mesenteric lymph nodes, with afferent vessels entering and efferent vessels leaving the nodes. Successive collectors join the intestinal lymphatic trunk or trunks. They usually communicate with the cisterna chyli, an expanded origin of the thoracic duct in the upper lumbar region, near the bodies of L1–L2 and to the right of the aorta. The cisterna chyli also receives lymph from lumbar trunks; the stream beyond it therefore contains material from more than the intestine. A conspicuous sac is not present in every individual.

The thoracic duct passes through the aortic hiatus of the respiratory diaphragm and ascends in the posterior mediastinum, typically between the aorta and azygos vein, behind the oesophagus. It crosses towards the left in the middle or upper thorax, continues to the root of the neck and arches to its terminal venous opening. The usual endpoint is the left venous angle, where the left internal jugular vein joins the left subclavian vein; terminal branches and the precise opening show anatomical variation. It is not normally the right venous angle or a direct entrance into the portal vein.^[ref]

The flow is promoted by intrinsic contraction of collecting lymphatic vessels, movements of surrounding muscles and respiratory changes of pressure. Lymphatic valves limit backward movement. Lymph nodes are interposed biological structures, not pumps that propel every particle independently.^[ref]

This route applies particularly to the long-chain dietary lipids carried by chylomicrons. Most absorbed glucose and amino acids, and much shorter-chain fatty acid material, follow portal vascular routes instead. Confusing these pathways would obscure the reason for asking separately about chyle. In a classical anatomical demonstration, the mesenteric channels of an appropriately fed animal appear white, and an injected or dissected preparation can trace their continuity towards the thoracic duct. The timing after a fatty meal matters: an empty-looking channel in a fasted preparation does not prove absence of a lymphatic vessel. The molecular account of chylomicrons is a modern explanation of the older gross observation.

Use a qualitative separation into aqueous extract, lipid-soluble material, protein-rich residue and mineral matter, and test each fraction independently. A tubercle is a lesion containing several kinds of material, not a pure chemical compound with one diagnostic formula. The question asks how to investigate its composition; no observations or numerical composition are supplied.

First record the lesion's physical appearance and take a portion for microscopy before destructive treatment. Separate the lesion from surrounding tissue as far as practicable, while recording that contamination by blood, connective tissue or adherent salts can affect the analysis. Different stages of a lesion need not have the same proportions of organic material and calcified matter. A small portion gently dried in suitable apparatus shows whether much water is lost; collecting condensation supports identification of the volatile fraction as containing water, although mass loss alone is not a chemically specific water test.

On separate portions, or by a documented extraction sequence, examine the main fractions:

Test soluble salts using a fresh portion or a suitable water extract: for example, silver nitrate can detect chloride, while barium under controlled acidic conditions can detect sulfate. A chloride test should not be performed on material already contaminated with hydrochloric acid. The results identify constituents or operational fractions, not necessarily the precise salts originally present in intact tissue; ashing can also change their chemical forms.

If the intended composition is elemental rather than proximate, investigate an isolated organic fraction separately: oxidation with heated copper(II) oxide can convert its carbon into carbon dioxide and its hydrogen into water, which are trapped and identified independently. A suitable nitrogen determination can convert organic nitrogen into Ammonia for identification in a separate receiver. Mineral carbonate and pre-existing moisture must be controlled before attributing these products to the organic material. Such tests answer a different question from identifying the particular proteins or lipids.

This approach has a historical basis. Original analyses by Robert Mortimer Glover, reproduced in an 1847 review, separately extracted material with ethanol, diethyl ether and water, then examined protein-rich residues and mineral salts. They reported variation between lesions and did not consistently find casein. This evidence supports fractionation and caution about specificity, not one universal numerical recipe for all tubercles.^[ref]

A modern conclusion must separate composition from cause. A protein-, lipid- and phosphate-containing lesion is not thereby proved to be tuberculosis. Histological interpretation and appropriate microbiological examination are different investigations. Current confirmation of Mycobacterium tuberculosis involves validated tests such as nucleic acid amplification and culture, rather than the extraction reactions above; these are modern qualifications and are not attributed to the 1866 examination.^[ref]

Test metabolic response and verified exposure, rather than using body weight as the sole definition of efficacy. Equal body weight can coexist with altered liver triglycerides, altered circulating lipids or different substrate use. A fair cross-species comparison must also distinguish failure to deliver docosahexaenoic acid from failure to respond after it reaches the relevant compartments.

Parallel randomized interventions. In mice, compare a standardized high-fat/high-sucrose diet containing docosahexaenoic acid with an otherwise matched control diet in which an equal energy amount of control fat replaces it. Keep total fat, sugar, protein, micronutrients and energy density constant; measure actual food intake. Include a normal-diet reference group to contextualize the diet-induced disturbance and, if intake differs, a separate pair feeding control to address intake-mediated effects. The pair-fed group answers a different question from the freely fed control, so it should not replace it. Standardize age and housing, include both sexes with a planned analysis, and randomize across cages and processing batches. If diet is assigned by cage, replicate and analyze the cage-level assignment rather than treating all cage-mates as independent treatment allocations.

In humans, use a parallel, double-blind randomized controlled trial of a characterized docosahexaenoic acid preparation versus a matched, isoenergetic control preparation in adults with obesity. Choose the exposure under an approved clinical protocol, maintain background diet and activity as consistently as practical, and record medication, alcohol and other supplement use. Avoid combining one arm with an unbalanced weight-loss programme. The control oil is a defined comparator with its own possible biology, not an assumed metabolically inert substance. Block randomization on important baseline factors and blind clinical assessors and laboratory staff.

Choose dose and duration to compare achieved exposure, not simply the same milligrams per kilogram across species. Analyze the administered diets and preparations for fatty-acid composition and oxidation. Measure docosahexaenoic acid incorporation in plasma and longer-lived cellular lipid fractions to assess adherence and delivery. A predeclared study duration of roughly twelve weeks in humans, with a comparable mouse time course chosen for its biology, is an example design rather than a claim that identical calendar time implies identical metabolic exposure.

Samples and timing. Collect standardized fasting plasma before treatment and at early, intermediate and final visits, for example weeks 2, 6 and 12 in humans. In a subset, add a standardized-meal time course before and after intervention to measure postprandial trajectories rather than only a fasting endpoint. Record fasting duration, collection time, handling delay and recent diet. Collect urine for complementary small-molecule measurements. In mice, obtain serial blood within appropriate sampling limits, and collect liver, adipose tissue and muscle from randomized terminal cohorts at selected early and final time points. These terminal tissues are from different animals and must not be analyzed as within-animal repeated measurements.

Use comparable plasma fractions in both species for the primary cross-species analysis. Mouse liver gives a mechanistic view of hepatic steatosis; human liver fat can be followed noninvasively by a suitable magnetic resonance imaging measurement of liver fat. Do not require research liver biopsies solely to make the matrices match. Optional tissue collection must have separate justification. Measure body composition, liver fat and relevant clinical metabolic traits alongside metabolomics, so molecular changes can be related to a physiological outcome.

Analytical measurements. Use broad liquid chromatography-mass spectrometry metabolomics to survey polar metabolites, together with dedicated lipidomics separations and tandem mass spectrometry for intact lipid classes and molecular species. Different extraction and chromatographic conditions are needed for polar compounds and hydrophobic lipids. Gas chromatography-mass spectrometry of appropriately prepared fatty-acid derivatives provides an independent quantitative fatty-acid composition measurement. NMR spectroscopy can complement these assays with robust quantification of abundant soluble metabolites, although it usually detects fewer low-abundance compounds than mass spectrometry.

Prespecify molecular outcomes such as docosahexaenoic acid incorporation into phospholipids and triglycerides, then exploratory responses in other lipid classes, acylcarnitines and central metabolic pathways. A possible response is incorporation of more highly unsaturated lipid species without weight loss; reduced liver fat or altered postprandial handling could then reveal a metabolic effect missed by body weight. Conversely, altered precursor pools do not themselves prove increased pathway flux. Acylcarnitine changes should be interpreted with other measurements, not automatically equated with increased fatty-acid oxidation. These are hypotheses to test, not assumed treatment outcomes.

Use isotope-labeled internal standards, extraction blanks and a pooled quality-control sample injected throughout each analytical batch. Randomize sample order while balancing species, arm and time; include shared reference material across batches. Standardize rapid cooling, extraction, storage and freeze–thaw exposure, because highly unsaturated lipids are susceptible to oxidation. Verify key metabolite identities with retention behaviour, fragmentation and authentic standards where available. An accurate mass alone does not uniquely establish a lipid's double-bond positions or distinguish all structural isomers.

Statistical plan. Power the study for a limited set of primary biochemical or physiological endpoints, using anticipated variance and independent treatment units. Keep discovery lipidomics separate from confirmatory endpoints. Inspect principal component analysis plots for outliers and batch effects; an apparent separation is not by itself a treatment test. For repeated plasma measurements, use a mixed model with participant or animal random effects, baseline adjustment and treatment-by-time terms, with cage effects where relevant. Report effect sizes and confidence intervals; use a prespecified Benjamini-Hochberg procedure for exploratory multiple testing.

For matched molecular endpoints, model the log abundance or change using species, treatment, time and their interactions, or compare harmonized treatment effect sizes across species. A species-by-treatment interaction addresses differing responses. A significant result in mice and a nonsignificant result in humans does not establish that the responses differ. Differences in achieved exposure, sampled tissue, starting diet or baseline disease can still explain an apparent interaction; document these before attributing the difference to species physiology. Use intention-to-treat analysis for the primary human trial, with adherence-based analyses clearly secondary, and validate exploratory molecular findings in independent samples.

Ethics. Obtain informed consent and independent ethical review, explain uncertainty about benefit, protect identifiable molecular and clinical data, monitor adverse events and allow withdrawal. Do not induce obesity or require a harmful diet merely to mimic the mouse model, and do not withhold established care. Minimize blood and tissue sampling and justify any optional biopsy separately. Animal work likewise needs justified numbers, humane endpoints and refinement of sampling. The design should answer the cross-species question with the least invasive measurements that can distinguish exposure, molecular response and physiology.

Phospholipids are lipids containing a phosphate group as part of their structure linked by covalent bonds. The familiar membrane-forming phospholipids are amphiphilic: a hydrophilic head region with chemical polarity coexists with a hydrophobic, largely nonpolar hydrocarbon region. These descriptions refer to different parts of the same molecule, not to two separate substances. See IUPAC Gold Book: phospholipids and IUPAC Gold Book: amphiphilic.

A typical two-chain glycerophospholipid provides a useful example: a glycerol scaffold carries two fatty acid-derived acyl groups through ester linkages, plus a phosphate-containing head region. Phosphatidylcholine is one example. This scaffold describes an important subclass, rather than all phospholipids: sphingomyelin has a different backbone, and even glycerophospholipids need not all have two acyl groups. See IUPAC–IUB, Nomenclature of Lipids (1976), Lip-1.5 and Lip-2.1–2.6.

Polar does not mean negatively charged overall. At near-neutral pH, phosphatidylcholine is zwitterionic: its phosphate region carries negative electric charge and its choline region positive electric charge, with zero net electric charge for the molecule. Counting those opposite charges gives $(-1)+(+1)=0$; it does not remove their local interactions with water. See Lodish et al., Molecular Cell Biology: membrane lipids.

In a lipid bilayer, two membrane leaflets orient their hydrophilic heads toward the water on either side and their hydrophobic chains toward the shared interior. The hydrophobic effect helps explain this organization through the free energy of the water and lipids together. It is not a special repulsive chemical bond between chains and water. Which organization is favored also depends on molecular geometry, temperature, concentration, and the surrounding chemical solution; a phospholipid label alone does not guarantee a lipid bilayer. See Alberts et al., Molecular Biology of the Cell: the lipid bilayer.

This organization supplies a flexible barrier for compartments. A fluid lipid bilayer allows lipids to undergo diffusion within each membrane leaflet; barrier function therefore coexists with motion of molecules, as in the fluid mosaic model. It is not completely impermeable: small nonpolar molecules such as molecular oxygen and carbon dioxide cross much more readily than ions. In a cell membrane, ion channels and other membrane transport proteins provide selective routes; the existing membrane transport article explains their driving forces. See Alberts et al.: principles of membrane transport.

In 1925, E. Gorter and F. Grendel extracted lipids from red blood cells and compared the surface area of a one-molecule-thick film on water with the estimated total surface area of the red blood cells. Their table gave ratios near two, supporting a two-layer covering; they also proposed heads facing the aqueous surroundings on both sides. The inference depends on recovering the relevant lipids, estimating the red blood cell surface area correctly, and comparing compatible packing in the film and the cell membrane. It was indirect evidence, not an image of the lipid bilayer. The paper itself notes possible losses during evaporation. See Gorter and Grendel, On Bimolecular Layers of Lipoids on the Chromocytes of the Blood, Journal of Experimental Medicine 41 (1925), 439–443.

A polybasic region is a sequence enriched in basic, usually positively charged residues. In a membrane-targeting sequence, it can cooperate with a lipid anchor to promote association with negatively charged lipids.

protein lipidation is covalent attachment of a lipid group to a protein. Anchor chemistry, additional basic residues and other protein contacts together determine membrane residence and localization.

A scramblase facilitates relatively nonselective bidirectional movement of lipids between membrane leaflets, tending to dissipate asymmetry when active. Its action differs from directional transport used to maintain asymmetry.

Smooth endoplasmic reticulum lacks attached ribosomes. Specialized regions support lipid metabolism and processing of foreign compounds; the endoplasmic reticulum also stores and releases calcium ions. Regional specialization does not split the network into two separate organelles, nor make every smooth region perform every function.^[ref]